Cell therapy for Parkinson's symptoms
Part of Brain & nervous system clinical trials.
This study tests a new cell therapy called bemdaneprocel to see if it can reduce Parkinson's symptoms and “off” time. The treatment involves transplanting special cells into the brain to help replace lost dopamine-producing cells.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 45 and 75 years old.
- You have had Parkinson's for at least 4 years but less than 12 years.
- Your Parkinson's symptoms clearly improve with levodopa (like Sinemet), but you still have at least 2.5 hours of “off” time each day.
- You have not had any previous brain surgery, gene therapy, or cell therapy for Parkinson's.
- You are up to date on recommended vaccinations (since the treatment involves suppressing your immune system temporarily).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental gene therapy delivered to a specific brain area to help control Parkinson's symptoms. It is for people with advanced Parkinson's whose current medications no longer work well enough.
This trial tests a new treatment made from your own cells to replace damaged brain cells, aiming to improve movement and reduce symptoms. It's for people who have had Parkinson's for at least 4 years and respond well to levodopa.
This trial tests a new cell treatment for Parkinson's disease. It involves injecting special cells into the brain to see if they can safely replace damaged cells and improve symptoms. It might help people who have had Parkinson's for several years and still respond well to medication.
This trial tests a new cell therapy called NouvNeu001 for Parkinson's disease. It involves a one-time brain surgery to deliver the treatment, and researchers will check if it's safe and helps with symptoms.
This trial tests whether implanting your own stem cells (made into dopamine-producing brain cells) can improve Parkinson's motor symptoms. You would need to be a candidate for brain surgery and have a stable medication routine.
This trial tests whether transplanting specially grown cells (DopaCell) into the brain can safely help people with moderate Parkinson's disease whose symptoms aren't well controlled by medication. The cells are intended to produce dopamine, the chemical that Parkinson's affects.
Hear when a new Parkinsons Disease (PD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.